48 results
DEFA14A
ACGN
Aceragen Inc
30 Sep 22
Additional proxy soliciting materials
4:18pm
a conflict of interest with the Company. Nothing in this Letter Agreement will prevent you (i) from accepting speaking or presentation engagements … or indirectly engage or participate in any business that is competitive in any manner with the business of the Company or that would create a conflict
8-K
EX-10.2
ACGN
Aceragen Inc
30 Sep 22
Entry into a Material Definitive Agreement
4:15pm
of the Company or that would create a conflict of interest with the Company. Nothing in this Letter Agreement will prevent you (i) from accepting
8-K
EX-10.3
ACGN
Aceragen Inc
30 Sep 22
Entry into a Material Definitive Agreement
4:15pm
or indirectly engage or participate in any business that is competitive in any manner with the business of the Company or that would create a conflict … of interest with the Company. Nothing in this Letter Agreement will prevent you (i) from accepting speaking or presentation engagements in exchange
8-K
EX-10.1
unhllul5kbx 6mnte0
23 Dec 19
Idera Pharmaceuticals Announces Private Placement Up To $97.7 Million
4:01pm
425
EX-2.1
c77nnoar4
22 Jan 18
Business combination disclosure
12:00am
425
EX-2.1
dqdm j9c2ztv
22 Jan 18
Business combination disclosure
12:00am